AstraZeneca, LegoChem Biosciences To Co-Develop Novel Antibiotics

AstraZeneca has licensed an antibiotic drug candidate from South Korea's LegoChem Biosciences to treat drug-resistant bacterial infections.

Ironwood, AstraZeneca To Develop Linaclotide In China

AstraZeneca and Ironwood Pharmaceuticals, Inc. announced this week an agreement to co‐develop and co‐commercialize Ironwood’s linaclotide in China.

AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma

AstraZeneca will acquire Guangdong BeiKang Pharmaceutical Company Ltd, a privately-owned generics manufacturing company in Guangdong province, China.

AstraZeneca Invests US$200m Into Manufacturing Facility In China Medical City

AstraZeneca today announced a US$200 million investment in a new manufacturing facility, located in China Medical City, Taizhou, Jiangsu province in Eastern China.